Role of Laryngopharyngeal Reflux Changes in Children with Adenoid Hypertrophy: A Randomized Controlled Prospective Study

Table 5

Patients characteristics.

	Total (n = 43)	LPR (+) (n = 8)	LPR (−) (n = 35)
Age	6.73 ± 3.08	6.91 ± 3.04	6.52 ± 2.82	0.51
Sex (no, %)
Female	20 (46.4%)	5 (62.5%)	20 (57.1%)	0.39
Male	23 (53.5%)	3 (37.5%)	15 (42.9%)
LPR (median)	20	49	27	0.70
Acid regurgitation (median)	12	46	20	0.06
Mouth breathing (no, %)	34 (79.1%)	5 (62.5%)	29 (82.9%)	0.70
Snoring (no, %)	28 (65.1%)	4 (50%)	24 (68.6%)	0.34
Stoppage of breathing (no, %)	3 (6.9)	1 (1.3%)	2 (5.7%)	0.40
URTI (no, %)	4 (9.3%)	2 (25%)	2 (5.7%)	0.28
Heartburn (no, %)	2 (4.7%)	1 (1.3%)	1 (2.9%)	0.08

URTI: upper respiratory tract infection; LPR: laryngopharyngeal reflux.